GlassScriptPhysician profile
Nicole Renae King
NPI 1184945198
$2,731.32
in general payments reported to CMS, 2019-2025
32 companies · $613 in 2025
The $613 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $386 · 2020: $65.89 · 2021: $112 · 2022: $258 · 2023: $815 · 2024: $483 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,910.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $409.24 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $364.45 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $266.93 | 2019-2025 | Veozah |
| Novo Nordisk INC | $191.37 | 2019-2025 | Wegovy |
| Coopersurgical, INC. | $179.65 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Mayne Pharma Commercial LLC | $165.31 | 2022-2025 | |
| Exeltis, USA INC. | $160.92 | 2019-2025 | Slynd |
| Biogen, INC. | $104.42 | 2024-2025 | Zurzuvae |
| Exact Sciences Corporation | $96.63 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lilly USA, LLC | $95.63 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $77.21 | 2021-2023 | |
| Agile Therapeutics, INC. | $75.97 | 2021-2022 | |
| Hologic Sales and Service, LLC | $72.85 | 2019-2025 | Fluent Fluid Management System, Novasure, Myosure Tissue Removal Device |
| Daiichi Sankyo INC. | $60.78 | 2019 | |
| Therapeuticsmd, INC. | $52.84 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $49.59 | 2023-2025 | Accrufer |
| Organon LLC | $43.02 | 2023-2025 | Nexplanon |
| Minerva Surgical, INC | $29.75 | 2023 | |
| Amag Pharmaceuticals, INC. | $26.05 | 2020 | |
| Meditrina | $25.89 | 2023 | |
| Medtronic, INC. | $21.92 | 2023 | Interstim |
| Axonics, INC. | $20.66 | 2023 | Axonics |
| Pacira Pharmaceuticals Incorporated | $19.82 | 2022 | |
| Evofem Biosciences, INC. | $18.81 | 2022 | |
| Avion Pharmaceuticals | $14.40 | 2022 | |
| Millicent US INC | $13.81 | 2025 | Femlyv |
| Merck Sharp & Dohme LLC | $12.78 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.47 | 2019 | |
| Allergan, INC. | $12.36 | 2019 | |
| Lupin INC. | $12.11 | 2020 | |
| Asensus Surgical, INC. | $12.00 | 2019 | |
| Duchesnay USA Incorporated | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.